Settlement Talks Held By Actavis, Justice Department In Warner Chilcott Investigation
In news from another Justice Department probe, PharMerica agreed to pay $31.5 million over charges that it dispensed drugs without a prescription and submitted false Medicare claims.
The Wall Street Journal:
Actavis Has Discussed Settling Federal Probe Of Warner Chilcott Sales Tactics
Drug maker Actavis PLC has held discussions with the Justice Department about resolving an investigation into the marketing tactics at a division, including allegations of improper payments to doctors, according to a regulatory filing and court documents. (Loftus, 5/14)
Reuters:
Actavis Says Warner Chilcott Unit Held Talks To Settle U.S. Probe
Drug maker Actavis Plc said its Warner Chilcott unit held talks with U.S. government officials to discuss a potential resolution of an investigation into the unit's sales activities, according to a regulatory filing. ... Warner Chilcott said the company and several of its employees in the sales organization received subpoenas in 2012 from the United States Attorney for the District of Massachusetts. The subpoenas demanded information related to sales and marketing activities, payments to people who are in a position to recommend drugs, medical education and employee training, including physician remuneration, in connection with certain Warner Chilcott products. (5/14)
Reuters:
PharMerica To Pay $31.5 Million In Drug Dispensing Probe: Justice Department
PharMerica will pay the United States $31.5 million to resolve allegations that it improperly dispensed controlled drugs without a prescription and submitted false Medicare claims for these drugs, the U.S. Department of Justice said on Thursday. (5/14)
